GPR55: metabolic help or hindrance?

Christopher Henstridge; Andrew J. Brown; Maria Waldhoer

doi:10.1016/j.tem.2016.04.012

GPR55: metabolic help or hindrance?

Christopher Henstridge
, Andrew J. Brown
, Maria Waldhoer

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. We discuss conflicting evidence surrounding GPR55 physiology and highlight its potential as a novel target for the treatment of obesity and diabetes.

Original language	English
Pages (from-to)	606-608
Number of pages	3
Journal	Trends in Endocrinology and Metabolism
Volume	27
Issue number	9
DOIs	https://doi.org/10.1016/j.tem.2016.04.012
Publication status	Published - 21 May 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.tem.2016.04.012

Cite this

@article{3273280cc3694d35949888c0885bdf1d,

title = "GPR55: metabolic help or hindrance?",

abstract = "Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. We discuss conflicting evidence surrounding GPR55 physiology and highlight its potential as a novel target for the treatment of obesity and diabetes.",

author = "Christopher Henstridge and Brown, \{Andrew J.\} and Maria Waldhoer",

year = "2016",

month = may,

day = "21",

doi = "10.1016/j.tem.2016.04.012",

language = "English",

volume = "27",

pages = "606--608",

journal = "Trends in Endocrinology and Metabolism",

issn = "1043-2760",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - GPR55

T2 - metabolic help or hindrance?

AU - Henstridge, Christopher

AU - Brown, Andrew J.

AU - Waldhoer, Maria

PY - 2016/5/21

Y1 - 2016/5/21

N2 - Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. We discuss conflicting evidence surrounding GPR55 physiology and highlight its potential as a novel target for the treatment of obesity and diabetes.

AB - Since the discovery of the lysophospholipid-sensitive receptor GPR55, hopes have been raised that targeting this G protein-coupled receptor (GPCR) may represent a novel approach for the treatment of metabolic disorders. We discuss conflicting evidence surrounding GPR55 physiology and highlight its potential as a novel target for the treatment of obesity and diabetes.

U2 - 10.1016/j.tem.2016.04.012

DO - 10.1016/j.tem.2016.04.012

M3 - Article

SN - 1043-2760

VL - 27

SP - 606

EP - 608

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

IS - 9

ER -

GPR55: metabolic help or hindrance?

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this